# ðŸ§¬ Cancer Mutation Detection and Classification
### Mutation-Contextâ€“Aware Pan-Cancer Classification using TCGA Somatic Mutations

<p align="center">
  <strong>Bioinformatics â€¢ Cancer Genomics â€¢ Machine Learning</strong><br>
  TCGA Pan-Cancer Atlas Â· Mutation Signatures Â· Interpretable ML
</p>

---

## Project Motivation

Cancer is fundamentally a **genetic disease**, driven by the accumulation of **somatic mutations** that disrupt critical cellular pathways. Large-scale cancer genomics initiativesâ€”most notably **The Cancer Genome Atlas (TCGA)**â€”have revealed that tumors are shaped not only by mutations in *driver genes*, but also by the **mutational processes** that generate these alterations.

These processesâ€”such as aging-related deamination or smoking-induced DNA damageâ€”leave distinct **sequence-contextâ€“dependent mutation patterns**, commonly referred to as **mutational signatures**. Importantly, such patterns differ systematically across tissues and cancer types.

**This project investigates whether somatic mutation data alone**, when represented using biologically informed features, can be used to **accurately and interpretably classify cancer types** using machine learning.

---

## Objectives

- Process large-scale TCGA somatic mutation data  
- Retain high-confidence **non-synonymous mutations**  
- Engineer biologically meaningful mutation-derived features:
  - Tumor mutational burden  
  - Mutation class composition  
  - Gene-level mutation frequencies  
  - Trinucleotide (96-context) mutation signatures  
- Train and compare multiple machine-learning models  
- Interpret key biological drivers of model predictions  

---

## Data Sources

### **TCGA Pan-Cancer Atlas (MC3)**
- Harmonized somatic mutation dataset
- Consensus mutation calls across multiple pipelines
- High-confidence variants suitable for pan-cancer analysis

### **Clinical Metadata**
- Cancer type labels from TCGA project identifiers  
- Survival data obtained but not modeled in this study  

### **Reference Data**
- **GRCh37 (hg19)** reference genome for mutation context extraction  
- **COSMIC Cancer Gene Census** for curated cancer genes  

---

## Cancer Types Analyzed

To balance biological diversity with robust sample sizes, six cancer types were selected:

| Code | Cancer Type |
|-----:|-------------|
| BRCA | Breast Invasive Carcinoma |
| COAD | Colon Adenocarcinoma |
| LUAD | Lung Adenocarcinoma |
| LUSC | Lung Squamous Cell Carcinoma |
| PRAD | Prostate Adenocarcinoma |
| STAD | Stomach Adenocarcinoma |

---

## Methodology Overview

### 1. Mutation Processing
- Retained **non-synonymous somatic mutations** only  
- Aggregated variant-level data to **tumor-sampleâ€“level vectors**

### 2. Feature Engineering

#### **Mutation Burden & Variant-Type Features**
- Total mutation count per tumor  
- Counts of missense, nonsense, frameshift, splice-site mutations  

#### **Gene-Level Mutation Features**
- Mutation counts for the **top 50 most frequently mutated genes**
- Preserves quantitative signal while limiting dimensionality

#### **Trinucleotide Mutation Context Features**
- Extraction of 5â€² and 3â€² flanking bases from hg19
- Normalization to pyrimidine context
- Construction of **96 trinucleotide mutation categories**
- Per-sample normalization to relative frequencies

These features approximate known **COSMIC mutational signatures** and capture underlying mutational processes.

---

## Machine Learning Framework

- Problem formulated as a **6-class classification task**
- Models evaluated:
  - Random Forest
  - XGBoost
  - LightGBM
  - Stacked ensemble (evaluated, not selected)

**Evaluation Metrics**
- Accuracy  
- Precision / Recall  
- **Macro-averaged F1-score** (primary metric)

---

## Final Model & Performance

**Best Model:** Tuned **LightGBM**  
**Feature Set:**
- Mutation burden features  
- Gene-level mutation counts  
- 96-context mutation signatures  

### Performance
- **Accuracy:** ~**75%**
- **Macro F1-score:** ~**0.74**

Strong performance was observed for **LUSC, COAD, and BRCA**, with biologically meaningful confusion patterns between related cancer types.

---

## Interpretability & Biological Insight

Feature importance analysis shows:

- Trinucleotide mutation contexts dominate predictive power  
- C>T and C>A substitutions align with known mutational processes  
- Gene-level features (e.g., **TP53**, **KRAS**, **PIK3CA**, **APC**) provide complementary biological signal  

This confirms that **mutational processes**, not only driver genes, are essential for mutation-based cancer classification.

---

## Repository Structure


cancer-mutation-classification/
â”œâ”€â”€ data_raw/                # Original TCGA & reference data
â”œâ”€â”€ data_processed/          # Cleaned data and engineered features
â”œâ”€â”€ notebooks/               # Analysis notebooks (run sequentially)
â”œâ”€â”€ src/                     # Reusable Python modules
â”œâ”€â”€ results/                 # Figures, tables, saved models
â”œâ”€â”€ reports/                 # Paper draft and presentation
â”œâ”€â”€ README.md
â”œâ”€â”€ requirements.txt
â””â”€â”€ environment.yml


---

## How to Run

### Environment Setup

```bash
conda env create -f environment.yml
conda activate cancer-mutation-classification

or

pip install -r requirements.txt

```

## Notebook Execution Order

Run the notebooks in the following order to reproduce the full pipeline:

1. **`01_data_loading_and_qc.ipynb`**  
   Load TCGA mutation and clinical data, perform quality control and filtering.

2. **`02_exploratory_data_analysis.ipynb`**  
   Explore mutation burden, mutation spectra, and cancer-type distributions.

3. **`03_feature_engineering.ipynb`**  
   Construct mutation burden, gene-level, and mutation signature features.

4. **`04_model_training_and_evaluation.ipynb`**  
   Train and evaluate Random Forest, XGBoost, and LightGBM models.

5. **`05_interpretation_and_reporting.ipynb`**  
   Analyze feature importance, confusion matrices, and export final results.

---

## Limitations & Future Work

### Current Limitations
- Analysis limited to **six cancer types** to control class imbalance
- Only **somatic mutation data** considered
- No integration of **gene expression**, **copy number variation**, or **epigenetic data**

### Future Extensions
- Extension to **full TCGA pan-cancer classification**
- Explicit **COSMIC mutational signature deconvolution** (e.g., SBS1, SBS4)
- Validation on **external, non-TCGA datasets**
- Integration of additional molecular modalities for improved performance

---

## References

Key references supporting this work include:

- Vogelstein et al., *Science*, 2013  
- Jiao et al., *Nature Communications*, 2020  
- Zeng et al., *BMC Bioinformatics*, 2021  
- Sun et al., *Scientific Reports*, 2023  
- TCGA Pan-Cancer Atlas publications  

*A complete reference list is provided in*  
`reports/paper/references.bib`

---

## Author

**Abdelrhman Akram Youssef**  
Biomedical Informatics / Bioinformatics Project  
Nile University

